MAUI Imaging Raises $14 Million

MAUI Imaging 获得 1400 万美元融资

Acertara Acoustic Laboratories leads round for FDA-cleared imaging technology that reveals anatomy traditional ultrasound devices cannot

Acertara声学实验室引领FDA认证的成像技术，揭示传统超声设备无法显示的解剖结构

TUCSON, Ariz., July 29, 2025-- MAUI Imaging, inventor of patented technology that visualizes anatomy other ultrasound technologies cannot, today announced raising $14 million in a Series D round, including equity funding, and led by Acertara Acoustic Laboratories. The funding is allocated to support the production, sales and marketing of the company's Computed Echo Tomography-based imaging technology..

亚利桑那州图森市，2025年7月29日 —— MAUI Imaging公司是拥有专利技术的发明者，该技术能够可视化其他超声技术无法显示的解剖结构。该公司今日宣布在D轮融资中筹集了1400万美元，包括股权融资，本轮融资由Acertara Acoustic Laboratories领投。这笔资金将用于支持公司基于计算回声断层成像技术的生产、销售和营销。

'With this support and our work with the U.S. military we are able to address the clear need for a new ultrasound-based technology to image all types of tissues,' said MAUI Imaging CEO and co-founder David Specht. 'That need is most pronounced in trauma medicine, which is a major focus for us. MAUI will also be able to supply the volumetric imaging data for increasingly accessible and advanced AI tools that stand to transform medicine.'.

“有了这一支持，以及我们与美国军方的合作，我们能够满足对基于超声波的新技术的明确需求，以成像所有类型的组织，”MAUI Imaging首席执行官兼联合创始人大卫·施佩希特表示。“这种需求在创伤医学中尤为突出，这是我们关注的重点之一。MAUI还将能够为日益普及和先进的AI工具提供体积成像数据，这些工具有望彻底改变医学。”

MAUI Imaging is currently delivering devices to initial users. Acertara is leading pre-orders with an exclusive U.S. distributorship for hospitals outside of those MAUI Imaging serves directly.

MAUI Imaging目前正在向初始用户交付设备。Acertara正通过其在美国的独家分销权领导预购，面向MAUI Imaging直接服务范围之外的医院。

Levi Moore, President and CEO of Acertara Acoustic Labs commented 'The MAUI ultrasound system represents a major advancement in medical imaging. By reducing the complexity of image acquisition and offering an intuitive approach, it expands ultrasound's reach to new users and clinical settings. We're working closely with MAUI to accelerate adoption in hospitals nationwide, where this technology has the potential to save lives and significantly improve patient outcomes.'.

Acertara声学实验室总裁兼首席执行官Levi Moore评论道：“MAUI超声系统代表了医学影像领域的一项重大进步。通过简化图像采集的复杂性并提供直观的操作方式，它将超声技术的应用扩展到了更多新用户和临床环境中。我们正在与MAUI密切合作，加速该技术在全国医院的推广，这项技术有潜力挽救生命并显著改善患者的治疗效果。”

MAUI Imaging emerged from stealth in August 2024 with the announcement of a $4 million U.S. Department of Defense (US Army Medical Research and Development Command) contract to support trauma medicine across four branches of the military seeking to enable faster diagnosis and interventional care in high volume or mass casualty events and resource limited environments..

MAUI Imaging于2024年8月走出隐匿模式，宣布获得了一份价值400万美元的美国国防部（美国陆军医学研究与开发司令部）合同，以支持跨四个军种的创伤医学，旨在高流量或大规模伤亡事件以及资源有限的环境中实现更快的诊断和干预护理。

Department of Defense:

国防部：

The USAMRDC-enabled program is sponsored by the Office of the Assistant Secretary of Defense for Health Affairs through the Combat Casualty Care Research Program under Award No. HT9425-23-3-0002. It is being implemented at the University of Maryland Shock Trauma Center in Baltimore, which is one of the major trauma centers where the military trains trauma surgeons and other related health care providers..

由美国军方医学研究与发展司令部（USAMRDC）支持的项目，由国防卫生事务助理部长办公室通过战伤护理研究计划资助，奖项编号为HT9425-23-3-0002。该项目正在巴尔的摩的马里兰大学休克创伤中心实施，该中心是军队培训创伤外科医生及其他相关医疗人员的主要创伤中心之一。

A committee of independent expert physicians reported that MAUI represents a categoric change in ultrasound imaging that offers the potential for significantly improving patient management in emergent settings, regardless of the availability of other imaging modalities. In certain cases, like cranial and spinal imaging in adults, where traditional ultrasound has not been traditionally employed, MAUI has been reported to provide clinically meaningful images needed by physicians to diagnose, triage, and treat serious injuries.

一个独立专家医生委员会报告称，MAUI代表了超声成像的绝对变革，无论其他成像方式是否可用，它都有潜力显著改善急诊环境中的患者管理。在某些情况下，例如传统超声通常未被应用的成人颅脑和脊柱成像，据报道MAUI能够提供医生诊断、分诊和治疗严重损伤所需的具有临床意义的图像。

Traditional ultrasound cannot image intracranially without a significant 'window' into the skull involving large fractures or surgically removed bone. As a result, patients require CT or MRI scans which are often unavailable. MAUI is designed to change this and aims to decrease time to diagnosis and treatment..

传统超声波无法在没有显著颅骨“窗口”的情况下对颅内进行成像，这通常需要大的骨折或手术切除的骨头。因此，患者需要进行CT或MRI扫描，但这些设备往往无法及时获取。MAUI旨在改变这一现状，致力于缩短诊断和治疗的时间。

Views and conclusions contained in this release are those of MAUI Imaging and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the U.S. Government.

本发布文件中的观点和结论均为茂宜岛成像公司所有，不应被解释为必然代表美国政府的官方政策或认可，无论是明示还是暗示。

MAUI's 510K FDA clearance:

MAUI的510K FDA认证：

In October 2023, the MAUI K3900 device received its 510(k) FDA clearance and is now available for commercial use.

2023年10月，MAUI K3900设备获得了510(k) FDA许可，现在可以用于商业用途。

The MAUI K3900 Ultrasound Imaging System is intended for use by qualified healthcare personnel in environments where healthcare is provided for ultrasound evaluation of Fetal; Abdominal; Pediatric; Small Organ (breast, testes, thyroid); Neonatal Cephalic; Adult Cephalic; Cardiac (adult and pediatric); Peripheral Vascular; Musculo-skeletal Conventional and Superficial; Urology (including prostate); and Intraoperative (abdominal, thoracic and vascular).

MAUI K3900超声成像系统旨在供合格的医疗保健人员在提供医疗服务的环境中使用，用于胎儿、腹部、儿科、小器官（乳腺、睾丸、甲状腺）、新生儿头颅、成人头颅、心脏（成人和儿科）、外周血管、肌肉骨骼常规及浅表、泌尿科（包括前列腺）以及术中（腹部、胸腔和血管）的超声评估。

Examples of differentiating images for use in trauma, neurosurgery and interventional radiology can be found at mauiimaging.com/solutions..

可以在mauiimaging.com/solutions找到用于创伤、神经外科和介入放射学的不同图像示例。

MAUI's Patented Computed Echo Tomography (CET):

MAUI的专利计算回声断层扫描（CET）：

MAUI Imaging has created a novel and effective approach to diagnostic imaging resultant in a cross between ultrasound and CT without the need for dangerous ionizing radiation (x-rays). MAUI's CET 'pings' the designated part of the human body, uniquely visualizing anatomy beyond what other ultrasound systems can produce.

MAUI Imaging创造了一种新颖且有效的诊断成像方法，结合了超声和CT的特点，且无需使用危险的电离辐射（X射线）。MAUI的CET“探测”人体指定部位，能够独特地展现解剖结构，超越其他超声系统所能产生的效果。

MAUI then uses proprietary patented algorithms to accommodate the reflected energy from various flight paths and sums the data to create a reliable image of all the structures below the probe. Barriers such as bone, gas, fat, instruments, implants, etc. become part of the image instead of obstacles to image formation.

MAUI接着使用专有的专利算法来适应来自各飞行路径的反射能量，并将数据汇总以创建探头下方所有结构的可靠图像。骨骼、气体、脂肪、器械、植入物等屏障成为图像的一部分，而非成像的障碍。

MAUI is currently performing clinical studies with the military and elsewhere to fully demonstrate these capabilities..

MAUI目前正在军队及其他地方进行临床研究，以充分证明这些能力。

MAUI's core patents deal with solving speed-of-sound aberration issues in tissue, enabling views of a variety of tissue types, including lung and cranium, previously thought to be unobtainable. MAUI's portfolio includes more than 160 granted patents and dozens more pending in and outside the U.S.

MAUI的核心专利涉及解决组织中的声速畸变问题，使得观察包括肺和颅骨在内的多种组织类型成为可能，而这些以前被认为是无法获得的。MAUI的专利组合包括160多项已授权专利，还有数十项正在美国及其它地区申请中。

MAUI uses a concave probe that fires pulses (pings) into the tissue from many different angles. The MAUI probe's concave shape sends and receives energy from multiple angles, one of the reasons that allow MAUI to see through and around traditional barriers. This ability is unknown to other ultrasound-based systems.

MAUI 使用一种凹形探头，从多个不同角度向组织发射脉冲（声波）。MAUI 探头的凹形设计能够从多个角度发送和接收能量，这是其能够穿透并绕过传统屏障的原因之一。这种能力在其他基于超声波的系统中是未知的。

MAUI probe apertures can also be much larger than traditional probes as they do not need to navigate between barriers, such as the ribs, making it more easily positioned over regions of interest. While a highly trained sonographer technician or physician is typically required to acquire images around the ribs in order to aim at what they want to visualize, with MAUI, the user can see beyond barriers without requiring more invasive imaging approaches..

MAUI 探头的孔径也可以比传统探头大得多，因为它们不需要在诸如肋骨之类的屏障之间导航，这使得它更容易定位在感兴趣的区域上。通常需要经过高度训练的超声技师或医生才能在肋骨周围获取图像，以便瞄准他们想要观察的目标，而使用 MAUI 时，用户可以越过屏障看到目标，而无需依赖更具侵入性的成像方法。

The MAUI approach requires trillions of calculations per second and would not have been possible in a portable, cost-effective solution without chip advances often described as Moore's Law. MAUI's approach also creates a significantly larger data set that can be sliced into as many images as necessary, more like CT than traditional ultrasound.

MAUI 方法每秒需要进行数万亿次计算，如果没有通常被描述为摩尔定律的芯片技术进步，这种方法不可能在便携式、经济高效的解决方案中实现。MAUI 方法还创建了一个显著更大的数据集，可以将其切分为任意多的图像，更像 CT 而不是传统的超声波。

The datasets that MAUI produces can be used for deeper analytics, providing more insight about the anatomy it scans. MAUI's volumetric imaging has the potential to significantly expand the role of ultrasound in AI-driven diagnostics..

MAUI 生成的数据集可用于更深入的分析，提供关于其扫描解剖结构的更多见解。MAUI 的容积成像有潜力显著扩展超声波在 AI 驱动诊断中的作用。

About MAUI

关于MAUI

MAUI Imaging's Computed Echo Tomography (CET), uses ultrasound to insonify tissues through and beyond barriers for rapid and effective imaging of the human body and is protected by more than 160 patents. MAUI's FDA Cleared system produces a large-scale dataset enabling novel insights that can assist in rapid and effective diagnosis and interventions.

MAUI Imaging的计算回声断层成像（CET）利用超声波通过并越过屏障对组织进行照射，从而快速高效地对人体进行成像，并受到160多项专利的保护。MAUI的FDA认证系统生成大规模数据集，能够提供全新见解，有助于快速有效的诊断和干预。

MAUI Imaging has multiple clinical sites and studies in process in trauma, neurosurgery, and interventional radiology. MAUI's CET system enables rapid imaging of the brain, and other internal organs and structures, in real time by existing clinical personnel without additional training. For more information visit mauiimaging.com..

MAUI Imaging在创伤、神经外科和介入放射学领域有多个临床站点和正在进行的研究。MAUI的CET系统使现有临床人员无需额外培训即可实时快速成像大脑及其他内部器官和结构。欲了解更多信息，请访问mauiimaging.com。

Contact:

联系人：

Media Contact:

媒体联系人:

Chris Gale

克里斯·盖尔

chris@galestrategies.com

克里斯@galestrategies.com